Expression of SLAM (CD150) cell-surface receptors on human B-cell subsets: From pro-B to plasma cells

Immunology Letters

Volumn 134, Issue 2, 2011, Pages 129-136

  De Salort, Jose ^a   Sintes, Jordi ^a   Llinàs, Laia ^a   Matesanz Isabel, Jessica ^a   Engel, Pablo ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

B cell subsets; CD150; Cell lines; Cell surface molecules; SLAM family

Indexed keywords

CD150 ANTIGEN; CD229 ANTIGEN; CD244 ANTIGEN; CD319 ANTIGEN; CD325 ANTIGEN; CD48 ANTIGEN; CD84 ANTIGEN; CELL SURFACE RECEPTOR; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW CELL; CELL MATURATION; CONTROLLED STUDY; FLOW CYTOMETRY; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOREGULATION; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; MOLECULAR DYNAMICS; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PLASMA CELL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SPLEEN LYMPHOCYTE; TONSIL CELL;

ANTIGENS, CD; B-LYMPHOCYTE SUBSETS; CELL LINE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HL-60 CELLS; HUMANS; JURKAT CELLS; K562 CELLS; PLASMA CELLS; PRECURSOR CELLS, B-LYMPHOID; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; U937 CELLS;

EID: 78650277943     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.09.021     Document Type: Article

References (55)

1. Cambier J.C., Pleiman C.M., Clark M.R. Signal transduction by the B cell antigen receptor and its coreceptors. Annu Rev Immunol 1994, 12:457-486.
2. MacLennan I.C. Germinal centers. Annu Rev Immunol 1994, 12:117-139.
3. LeBien T.W., Tedder T.F. B lymphocytes: how they develop and function. Blood 2008, 112:1570-1580.
4. Engel P., Eck M.J., Terhorst C. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat Rev Immunol 2003, 3:813-821.
5. Tangye S.G., Phillips J.H., Lanier L.L. The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells. Semin Immunol 2000, 12:149-157.
6. Sidorenko S.P., Clark E.A. The dual-function CD150 receptor subfamily: the viral attraction. Nat Immunol 2003, 4:19-24.
7. Morra M., Howie D., Grande M.S., Sayos J., Wang N., Wu C., et al. X-linked lymphoproliferative disease: a progressive immunodeficiency. Annu Rev Immunol 2001, 19:657-682.
8. Staunton D.E., Thorley-Lawson D.A. Molecular cloning of the lymphocyte activation marker Blast-1. EMBO J 1987, 6:3695-3701.
9. Veillette A., Dong Z., Latour S. Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes. Immunity 2007, 27:698-710.
10. Sayós J., Martín M., Chen A., Simarro M., Howie D., Morra M., et al. Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP. Blood 2001, 97:3867-3874.
11. Morra M., Lu J., Poy F., Martin M., Sayos J., Calpe S., et al. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells. EMBO J 2001, 20:5840-5852.
12. Latour S., Gish G., Helgason C.D., Humphries R.K., Pawson T., Veillette A. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat Immunol 2001, 2:681-690.
13. Calpe S., Wang N., Romero X., Berger S.B., Lanyi A., Engel P., et al. The SLAM and SAP gene families control innate and adaptive immune responses. Adv Immunol 2008, 97:177-250.
14. Chan A.Y., Westcott J.M., Mooney J.M., Wakeland E.K., Schatzle J.D. The role of SAP and the SLAM family in autoimmunity. Curr Opin Immunol 2006, 18:656-664.
15. Furukawa H., Tohma S., Kitazawa H., Komori H., Nose M., Ono M. Role of SLAM-associated protein in the pathogenesis of autoimmune diseases and immunological disorders. Arch Immunol Ther Exp (Warsz) 2010, 58:37-44.
16. Detre C., Keszei M., Romero X., Tsokos G.C., Terhorst C. SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions. Semin Immunopathol 2010, 32:157-171.
17. Schwartzberg P.L., Mueller K.L., Qi H., Cannons J.L. SLAM receptors and SAP influence lymphocyte interactions, development and function. Nat Rev Immunol 2009, 9:39-46.
18. McNerney M.E., Lee K.M., Kumar V. 2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells. Mol Immunol 2005, 42:489-494.
19. Tissot C., Rebouissou C., Klein B., Mechti N. Both human alpha/beta and gamma interferons upregulate the expression of CD48 cell surface molecules. J Interferon Cytokine Res 1997, 17:17-26.
20. Sintes J., Romero X., Marin P., Terhorst C., Engel P. Differential expression of CD150 (SLAM) family receptors by human hematopoietic stem and progenitor cells. Exp Hematol 2008, 36:1199-1204.
21. Gao N., Schwartzberg P., Wilder J.A., Blazar B.R., Yuan D. B cell induction of IL-13 expression in NK cells: role of CD244 and SLAM-associated protein. J Immunol 2006, 176:2758-2764.
22. Klyushnenkova E.N., Li L., Armitage R.J., Choi Y.S. CD48 delivers an accessory signal for CD40-mediated activation of human B cells. Cell Immunol 1996, 174:90-98.
23. Hoffmann J.C., Krüger H., Zielen S., Bayer B., Zeidler H. Human b cell differentiation: dependence on interactions with monocytes and T lymphocytes via CD40, CD80 (B7. 1), and the CD2-Ligands CD48 and CD58 (LFA-3). Cell Biol Int 1998, 22:21-29.
24. Good K.L., Avery D.T., Tangye S.G. Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol 2009, 182:890-901.
25. Yokoyama S., Staunton D., Fisher R., Amiot M., Fortin J.J., Thorley-Lawson D.A. Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. J Immunol 1991, 146:2192-2200.
26. Martin M., Romero X., de la Fuente M.A., Tovar V., Zapater N., Esplugues E., et al. CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1. J Immunol 2001, 167:3668-3676.
27. Krause S.W., Rehli M., Heinz S., Ebner R., Andreesen R. Characterization of MAX.3 antigen, a glycoprotein expressed on mature macrophages, dendritic cells and blood platelets: identity with CD84. Biochem J 2000, 346:729-736.
28. Tangye S.G., van de Weerdt B.C., Avery D.T., Hodgkin P.D. CD84 is up-regulated on a major population of human memory B cells and recruits the SH2 domain containing proteins SAP and EAT-2. Eur J Immunol 2002, 32:1640-1649.
29. de la Fuente M.A., Pizcueta P., Nadal M., Bosch J., Engel P. CD84 leukocyte antigen is a new member of the Ig superfamily. Blood 1997, 90:2398-2405.
30. Romero X., Benítez D., March S., Vilella R., Miralpeix M., Engel P. Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4). Tissue Antigens 2004, 64:132-144.
31. Sintes J., Romero X., De Salort J., Terhorst C., Engel P. Mouse CD84 is a pan-leukocyte cell-surface molecule that modulates LPS-induced cytokine secretion by macrophages. J Leukoc Biol 2010, 88(4):687-697.
32. Lee J.K., Boles K.S., Mathew P.A. Molecular and functional characterization of a CS1 (CRACC) splice variant expressed in human NK cells that does not contain immunoreceptor tyrosine-based switch motifs. Eur J Immunol 2004, 34:2791-2799.
33. Cannons J.L., Qi H., Lu K.T., Dutta M., Gomez-Rodriguez J., Cheng J., et al. Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity 2010, 32:253-265.
34. Cocks B.G., Chang C.C., Carballido J.M., Yssel H., de Vries J.E., Aversa G. A novel receptor involved in T-cell activation. Nature 1995, 376:260-263.
35. Kiel M.J., Yilmaz O.H., Iwashita T., Yilmaz O.H., Terhorst C., Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121:1109-1121.
36. Yurchenko M.Y., Kovalevska L.M., Shlapatska L.M., Berdova G.G., Clark E.A., Sidorenko S.P. CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells. Immunol Cell Biol 2010, 88:565-574.
37. Crotty S., Kersh E.N., Cannons J., Schwartzberg P.L., Ahmed R. SAP is required for generating long-term humoral immunity. Nature 2003, 421:282-287.
38. Hron J.D., Caplan L., Gerth A.J., Schwartzberg P.L., Peng S.L. SH2D1A regulates T-dependent humoral autoimmunity. J Exp Med 2004, 200:261-266.
39. de la Fuente M.A., Tovar V., Villamor N., Zapater N., Pizcueta P., Campo E., et al. Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9. Blood 2001, 97:3513-3520.
40. Bouchon A., Cella M., Grierson H.L., Cohen J.I., Colonna M. Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J Immunol 2001, 167:5517-5521.
41. Schuster P., Donhauser N., Pritschet K., Ries M., Haupt S., Kittan N.A., et al. Co-ordinated regulation of plasmacytoid dendritic cell surface receptors upon stimulation with herpes simplex virus type 1. Immunology 2010, 129:234-247.
42. Romero X., Zapater N., Calvo M., Kalko S.G., de la Fuente M.A., Tovar V., et al. CD229 (Ly9) lymphocyte cell surface receptor interacts homophilically through its N-terminal domain and relocalizes to the immunological synapse. J Immunol 2005, 174:7033-7042.
43. Valiante N.M., Trinchieri G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J Exp Med 1993, 178:1397-1406.
44. Nakajima H., Cella M., Langen H., Friedlein A., Colonna M. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur J Immunol 1999, 29:1676-1683.
45. Munitz A., Bachelet I., Fraenkel S., Katz G., Mandelboim O., Simon H.U., et al. 2B4 (CD244) is expressed and functional on human eosinophils. J Immunol 2005, 174:110-118.
46. Hsi E.D., Steinle R., Balasa B., Szmania S., Draksharapu A., Shum B.P., et al. CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma. Clin Cancer Res 2008, 14:2775-2784.
47. Lee J.K., Mathew S.O., Vaidya S.V., Kumaresan P.R., Mathew P.A. CS1 (CRACC, CD319) induces proliferation and autocrine cytokine expression on human B lymphocytes. J Immunol 2007, 179:4672-4678.
48. Antonysamy M.A., Thomson A.W. Flt3 ligand (FL) and its influence on immune reactivity. Cytokine 2000, 12:87-100.
49. Kim J.R., Mathew S.O., Patel R.K., Pertusi R.M., Mathew P.A. Altered expression of signalling lymphocyte activation molecule (SLAM) family receptors CS1 (CD319) and 2B4 (CD244) in patients with systemic lupus erythematosus. Clin Exp Immunol 2010, 160:348-358.
50. Bottino C., Falco M., Parolini S., Marcenaro E., Augugliaro R., Sivori S., et al. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J Exp Med 2001, 194:235-246.
51. Fraser C.C., Howie D., Morra M., Qiu Y., Murphy C., Shen Q., et al. Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family. Immunogenetics 2002, 53:843-850.
52. Valdez P.A., Wang H., Seshasayee D., van Lookeren Campagne M., Gurney A., Lee W.P., et al. NTB-A, a new activating receptor in T cells that regulates autoimmune disease. J Biol Chem 2004, 279:18662-18669.
53. Korver W., Singh S., Liu S., Zhao X., Yonkovich S., Sweeney A., et al. The lymphoid cell surface receptor NTB-A: a novel monoclonal antibody target for leukaemia and lymphoma therapeutics. Br J Haematol 2007, 137:307-318.
54. Pugh-Bernard A.E., Silverman G.J., Cappione A.J., Villano M.E., Ryan D.H., Insel R.A., et al. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest 2001, 108:1061-1070.
55. Yusuf I., Kageyama R., Monticelli L., Johnston R.J., Ditoro D., Hansen K., et al. Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150). J Immunol 2010, 185:190-202.